There are also FDA-approved generic liraglutide products for Victoza (for Type 2 diabetes and cardiovascular risk reduction) and Saxenda (for weight management)
This eligibility applies across all PlexusDx treatment options, including semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, tirzepatide injections, and oral formulations
ReadiSorb Glutathiones efficacy has been documented in many studies (see research page)
Mitochondrial abundance of GSH in HEK-293T SLC25A39 knockout cells expressing a vector control or SLC25A39 cDNA treated with GSH (5 mM) or GSHee (5 mM) for 24 hours
Early studies have found that the brains of people with PD, AD, MS and mild cognitive impairment (MCI), exhibit high levels of oxidative damage, including mitochondrial dysfunction, DNA and protein damage, lipid peroxidation, and myelin injury [62, 63]
In addition to their cardiovascular benefits, GLP-1 RAs also confer renal protection, demonstrating a 19% reduction in composite renal outcomes, a 16% reduction in end-stage kidney disease, a 21% reduction in kidney function decline [6]